ASCLS eNewsBytes
Sept. 23, 2008
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

West Nile May be down, But is it Out?
from the Boston Globe
West Nile virus, which made its U.S. debut nine years ago in New York and proceeded to spread coast to coast, appears to be in retreat this year, resulting in substantially fewer cases of human illness. A Globe analysis of federal figures shows that compared with the same period in 2007, half as many people this year have developed the most serious neurological complications of the mosquito-borne malady. More

Thermo Scientific

Guidelines Address Pharmacologic Treatments to Prevent Osteoporotic Fractures
from WebMD via MedScape Today
The American College of Physicians has issued an evidence-based guideline on various pharmacologic treatments to prevent fractures in men and women with low bone density or osteoporosis. The new recommendations are published in the Sept. 16 issue of the Annals of Internal Medicine. More

Help for Shopaholics: New Test Determines Who's at Risk for Compulsive Buying
from Science Daily
Shopaholics are the butt of many jokes, but obsessive or compulsive shopping can ruin lives. Compulsive shopping can lead to financial problems, family conflicts, stress, depression, and loss of self-esteem. More

Milk Sickens 50,000 Children
from CNN International
The World Health Organization said the tainted baby milk scandal that has killed four children and sickened nearly 53,000 others has highlighted flaws in the country's entire food supply chain. The chemical melamine blamed for causing kidney stones and kidney failure has been detected in formula milk powder from 22 dairies across China. More

Lasofoxifene May Soon be New SERM on the Block
from WebMD via MedScape Today
An investigational new selective estrogen-receptor modulator (SERM) is showing promise in the treatment of osteoporosis among postmenopausal women, according to research presented here at the American Society for Bone and Mineral Research 30th Annual Meeting. More

Polymedco

Decision Due Soon on Lilly, Daiichi Blood Thinner
from Reuters
Two large drug makers, Eli Lilly and Daiichi Sankyo companies, face a critical U.S. decision this week on their shared blood-clot preventer that could dramatically boost their bottom lines. The main study for the drug contained mixed results - potent effectiveness at preventing heart problems, but with heightened bleeding risks - leaving Wall Street weighing multiple scenarios for an FDA ruling. More

DeVry University Begins New Clinical Lab Science Degree Program in Arizona
from The Wall Street Journal
Addressing a shortage of skilled clinical laboratory scientists in the state of Arizona, DeVry University began teaching classes for a new bachelor's degree program in Clinical Laboratory Science at its Phoenix campus in September. DeVry University's Clinical Laboratory Science program is one of only two bachelor's degree programs of its kind offered in Arizona. More

Gene Epression Changes Predict Future Response for Cervical Cancer Patients
from Health Imaging News
Changes in gene expression during chemoradiation can predict the likelihood of response to therapy for women with locally advanced cervical cancer, according to research presented this week at the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology. More

Is That A Phone in Your Pocket?
from Newsweek
Just when you thought you were doing something good by using a hands-free cell-phone device, along comes a fertility specialist to put a damper on the party. According to a study published recently in the online version of the journal Fertility and Sterility, men who stash their cell phones in their pockets or clip them to their belts while using an earpiece to chat may also be compromising their sperm. More

Identification of Cells That Mediate Steroid-Resistant Asthma
from Medical News Today
Children's Hospital of Pittsburgh researchers have identified cells that may play a key role in some forms of steroid-resistant asthma, a complication of the condition that makes treatment even more challenging. The identification of a lineage of cells known as T Helper Type 17 (Th17) may help scientists in the development of new treatments that lead to better control of asthma. More




Proliant

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Ben Maitland, Director of Advertising Sales
972.402.7025

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Content Editor

Recent Issues

  • Aug. 11, 2009
  • Aug. 4, 2009
  • July 28, 2009
  • July 21, 2009
  • July 14, 2009

     RSS Feed